Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Physiology and pathophysiology of iron cardiomyopathy in thalassemia Wood JC; Enriquez C; Ghugre N; Otto-Duessel M; Aguilar M; Nelson MD; Moats R; Coates TDAnn N Y Acad Sci 2005[]; 1054 (ä): 386-95Iron cardiomyopathy remains the leading cause of death in patients with thalassemia major. Magnetic resonance imaging (MRI) is ideally suited for monitoring thalassemia patients because it can detect cardiac and liver iron burdens as well as accurately measure left ventricular dimensions and function. However, patients with thalassemia have unique physiology that alters their normative data. In this article, we review the physiology and pathophysiology of thalassemic heart disease as well as the use of MRI to monitor it. Despite regular transfusions, thalassemia major patients have larger ventricular volumes, higher cardiac outputs, and lower total vascular resistances than published data for healthy control subjects; these hemodynamic findings are consistent with chronic anemia. Cardiac iron overload increases the relative risk of further dilation, arrhythmias, and decreased systolic function. However, many patients are asymptomatic despite heavy cardiac burdens. We explore possible mechanisms behind cardiac iron-function relationships and relate these mechanisms to clinical observations.|Buffers[MESH]|Cardiac Output[MESH]|Cardiomegaly/etiology[MESH]|Cardiomyopathies/diagnosis/etiology/*physiopathology[MESH]|Chelation Therapy[MESH]|Combined Modality Therapy[MESH]|Heart/physiopathology[MESH]|Humans[MESH]|Iron Chelating Agents/therapeutic use[MESH]|Iron Overload/etiology/*physiopathology[MESH]|Iron/*metabolism[MESH]|Magnetic Resonance Imaging[MESH]|Models, Biological[MESH]|Oxidation-Reduction[MESH]|Stroke Volume[MESH]|Thalassemia/*complications/drug therapy/metabolism/therapy[MESH]|Transfusion Reaction[MESH]|Vascular Resistance[MESH] |
